Market Research Logo

Global Lung Cancer Liquid Biopsy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Global Lung Cancer Liquid Biopsy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer.

Scope of the Report:

This report studies the Lung Cancer Liquid Biopsy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lung Cancer Liquid Biopsy market by product type and applications/end industries.

CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time.

The global Lung Cancer Liquid Biopsy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lung Cancer Liquid Biopsy.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Biocept

Exosome Diagnostics

F. Hoffmann-La Roche

Qiagen

Accuragen

Agena Bioscience

Bard1

Bgi

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

CTCs

CtDNA

Exosomes And RNA

Others

Market Segment by Applications, can be divided into

Clinics

Hospitals

Physicians' Office Laboratories


1 Lung Cancer Liquid Biopsy Market Overview
1.1 Product Overview and Scope of Lung Cancer Liquid Biopsy
1.2 Classification of Lung Cancer Liquid Biopsy by Types
1.2.1 Global Lung Cancer Liquid Biopsy Revenue Comparison by Types (2017-2023)
1.2.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Types in 2017
1.2.3 CTCs
1.2.4 CtDNA
1.2.5 Exosomes And RNA
1.2.6 Others
1.3 Global Lung Cancer Liquid Biopsy Market by Application
1.3.1 Global Lung Cancer Liquid Biopsy Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Physicians' Office Laboratories
1.4 Global Lung Cancer Liquid Biopsy Market by Regions
1.4.1 Global Lung Cancer Liquid Biopsy Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Lung Cancer Liquid Biopsy Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Lung Cancer Liquid Biopsy Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lung Cancer Liquid Biopsy Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Lung Cancer Liquid Biopsy Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lung Cancer Liquid Biopsy Status and Prospect (2013-2023)
1.5 Global Market Size of Lung Cancer Liquid Biopsy (2013-2023)
2 Manufacturers Profiles
2.1 Biocept
2.1.1 Business Overview
2.1.2 Lung Cancer Liquid Biopsy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Biocept Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2016-2017)
2.2 Exosome Diagnostics
2.2.1 Business Overview
2.2.2 Lung Cancer Liquid Biopsy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Exosome Diagnostics Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2016-2017)
2.3 F. Hoffmann-La Roche
2.3.1 Business Overview
2.3.2 Lung Cancer Liquid Biopsy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2016-2017)
2.4 Qiagen
2.4.1 Business Overview
2.4.2 Lung Cancer Liquid Biopsy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Qiagen Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2016-2017)
2.5 Accuragen
2.5.1 Business Overview
2.5.2 Lung Cancer Liquid Biopsy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Accuragen Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2016-2017)
2.6 Agena Bioscience
2.6.1 Business Overview
2.6.2 Lung Cancer Liquid Biopsy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Agena Bioscience Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bard1
2.7.1 Business Overview
2.7.2 Lung Cancer Liquid Biopsy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bard1 Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bgi
2.8.1 Business Overview
2.8.2 Lung Cancer Liquid Biopsy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bgi Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2016-2017)
3 Global Lung Cancer Liquid Biopsy Market Competition, by Players
3.1 Global Lung Cancer Liquid Biopsy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Lung Cancer Liquid Biopsy Players Market Share
3.2.2 Top 10 Lung Cancer Liquid Biopsy Players Market Share
3.3 Market Competition Trend
4 Global Lung Cancer Liquid Biopsy Market Size by Regions
4.1 Global Lung Cancer Liquid Biopsy Revenue and Market Share by Regions
4.2 North America Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
4.3 Europe Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
4.5 South America Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
5 North America Lung Cancer Liquid Biopsy Revenue by Countries
5.1 North America Lung Cancer Liquid Biopsy Revenue by Countries (2013-2018)
5.2 USA Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
5.3 Canada Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
5.4 Mexico Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
6 Europe Lung Cancer Liquid Biopsy Revenue by Countries
6.1 Europe Lung Cancer Liquid Biopsy Revenue by Countries (2013-2018)
6.2 Germany Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
6.3 UK Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
6.4 France Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
6.5 Russia Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
6.6 Italy Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Lung Cancer Liquid Biopsy Revenue by Countries
7.1 Asia-Pacific Lung Cancer Liquid Biopsy Revenue by Countries (2013-2018)
7.2 China Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
7.3 Japan Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
7.4 Korea Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
7.5 India Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
8 South America Lung Cancer Liquid Biopsy Revenue by Countries
8.1 South America Lung Cancer Liquid Biopsy Revenue by Countries (2013-2018)
8.2 Brazil Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
8.3 Argentina Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
8.4 Colombia Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Lung Cancer Liquid Biopsy by Countries
9.1 Middle East and Africa Lung Cancer Liquid Biopsy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
9.3 UAE Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
9.4 Egypt Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
9.6 South Africa Lung Cancer Liquid Biopsy Revenue and Growth Rate (2013-2018)
10 Global Lung Cancer Liquid Biopsy Market Segment by Type
10.1 Global Lung Cancer Liquid Biopsy Revenue and Market Share by Type (2013-2018)
10.2 Global Lung Cancer Liquid Biopsy Market Forecast by Type (2018-2023)
10.3 CTCs Revenue Growth Rate (2013-2023)
10.4 CtDNA Revenue Growth Rate (2013-2023)
10.5 Exosomes And RNA Revenue Growth Rate (2013-2023)
10.6 Others Revenue Growth Rate (2013-2023)
11 Global Lung Cancer Liquid Biopsy Market Segment by Application
11.1 Global Lung Cancer Liquid Biopsy Revenue Market Share by Application (2013-2018)
11.2 Lung Cancer Liquid Biopsy Market Forecast by Application (2018-2023)
11.3 Clinics Revenue Growth (2013-2018)
11.4 Hospitals Revenue Growth (2013-2018)
11.5 Physicians' Office Laboratories Revenue Growth (2013-2018)
12 Global Lung Cancer Liquid Biopsy Market Size Forecast (2018-2023)
12.1 Global Lung Cancer Liquid Biopsy Market Size Forecast (2018-2023)
12.2 Global Lung Cancer Liquid Biopsy Market Forecast by Regions (2018-2023)
12.3 North America Lung Cancer Liquid Biopsy Revenue Market Forecast (2018-2023)
12.4 Europe Lung Cancer Liquid Biopsy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Lung Cancer Liquid Biopsy Revenue Market Forecast (2018-2023)
12.6 South America Lung Cancer Liquid Biopsy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Lung Cancer Liquid Biopsy Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report